Ignite Creation Date:
2024-05-05 @ 11:44 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00118183
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2005-07-08
Brief Title:
Docetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Organization:
National Cancer Institute NCI